In a patient with activity‑related fluctuating generalized weakness, intermittent ptosis, fatigable dysphonia, dysphagia, chewing difficulty, head‑droop and choking when supine, but with normal electromyography and negative acetylcholine‑receptor antibodies, could Myasthenia gravis be a differential or co‑existing disorder, and how can it be definitively ruled out?

Yes, Myasthenia Gravis remains a strong diagnostic possibility despite negative EMG and AChR antibodies, and can be definitively ruled out through additional antibody testing and single-fiber electromyography.

Your patient's clinical presentation is highly characteristic of MG—the fluctuating fatigable weakness, bulbar symptoms (dysphagia, dysphonia, chewing difficulty), ptosis, diplopia, head drop, and positional choking are classic features that should not be dismissed based on initial negative testing alone.

Why MG Remains on the Differential

Seronegative MG is Common

• Approximately 50% of patients with ocular MG and 20% of those with generalized MG are seronegative for AChR antibodies 1
• About one-third of these seronegative patients will be positive for muscle-specific kinase (MuSK) antibodies 1
• Lipoprotein-related protein 4 (LRP4) antibodies account for additional seronegative cases 2, 3

Standard EMG Has Limited Sensitivity

• Repetitive nerve stimulation testing is positive in only one-third of patients with ocular myasthenia 1
• Standard EMG may miss neuromuscular junction pathology entirely

Algorithmic Approach to Rule Out MG Completely

Step 1: Extended Antibody Panel (MANDATORY)

If AChR antibodies are negative, immediately order 2, 3:

• MuSK antibodies (IgG4 subclass)
• LRP4 antibodies
• Anti-striated muscle antibodies

This is critical because MuSK-positive MG has distinct clinical features that match your patient:

• Prominent bulbar weakness (dysphagia, dysphonia)
• Neck weakness (head drop)
• Respiratory involvement (choking when supine) 4

Step 2: Single-Fiber Electromyography (GOLD STANDARD)

Single-fiber EMG is positive in over 90% of patients with ocular myasthenia and is considered the gold standard for diagnosis 1. This test should be performed if antibody testing remains negative, as it is far more sensitive than repetitive nerve stimulation 2.

Step 3: Bedside Clinical Tests

Perform these highly specific tests 1:

Ice Pack Test:

• Apply ice pack over closed eyes for 2 minutes (ptosis) or 5 minutes (strabismus)
• Positive if ptosis reduces by ≥2mm or eye misalignment improves
• Highly specific for MG 1

Rest Test:

• Have patient rest with eyes closed for 30 minutes
• Reassess ptosis and diplopia
• Improvement suggests MG 1

Edrophonium (Tensilon) Test:

• 95% sensitive for generalized MG, 86% for ocular MG 1
• Must be performed in monitored setting with atropine available
• Caution: MuSK-MG patients may show hyperactivity (facial fasciculations, throat tightness) even to small doses 4

Step 4: Assess for Concurrent Conditions

Given the severity of symptoms, evaluate for 2, 3:

• CPK, aldolase, ESR, CRP (concurrent myositis)
• Troponin, ECG, echocardiogram (myocarditis—can coexist with MG)
• Pulmonary function tests with negative inspiratory force and vital capacity (respiratory muscle involvement)
• Brain/spine MRI (rule out CNS pathology mimicking MG)

Step 5: Neurology Consultation

Mandatory at this stage given the constellation of bulbar and generalized symptoms with potential for respiratory compromise 2, 3.

Critical Pitfalls to Avoid

1. Do not dismiss MG based on negative AChR antibodies alone—up to 50% of ocular MG cases are seronegative 1

2. Standard EMG is insufficient—you need single-fiber EMG or at minimum repetitive nerve stimulation with jitter studies 2

3. MuSK-MG behaves differently:

   • Poor response to pyridostigmine 4
   • May worsen with standard cholinesterase inhibitors
   • Requires different treatment approach (corticosteroids, immunosuppression)

4. Respiratory symptoms demand urgent evaluation—choking when supine suggests respiratory muscle weakness, which can progress to myasthenic crisis 2, 3

5. Consider therapeutic trial carefully: If all testing remains negative but clinical suspicion is high, a trial of pyridostigmine (starting 30mg PO three times daily, titrating to 120mg four times daily) may be diagnostic 2. However, avoid this in suspected MuSK-MG as it may worsen symptoms 4.

When MG is Definitively Ruled Out

MG can only be considered ruled out when:

• All three antibody tests (AChR, MuSK, LRP4) are negative AND
• Single-fiber EMG is normal AND
• Ice pack test and rest test are negative AND
• No response to edrophonium testing (if performed safely)

Even then, a small percentage of patients remain "double seronegative" but still have MG with low-affinity AChR antibodies detectable only by specialized assays 4.

Given your patient's classic fluctuating fatigable weakness with bulbar predominance, proceed immediately with MuSK and LRP4 antibody testing and arrange single-fiber EMG through neurology consultation. The combination of dysphagia, dysphonia, head drop, and positional choking is particularly concerning for MuSK-positive MG or impending respiratory crisis.